Board Meeting30 Oct 2026, 12:28 pm
Windlas Biotech Board Meeting on Nov 5 for Q2 FY27 Results
AI Summary
Windlas Biotech Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda item is to consider and approve the un-audited standalone financial results for the quarter and half-year ended September 30, 2026. Concurrently, the company has confirmed that its trading window remains closed from October 1, 2026, and will reopen 48 hours after the declaration of these financial results, in compliance with SEBI (Prohibition of Insider Trading) Regulations.
Key Highlights
- Board meeting scheduled for November 5, 2026.
- To approve un-audited standalone financial results.
- Results for the quarter and half-year ended September 30, 2026.
- Trading window closure and reopening procedures noted.
Price Impact
More from WINDLAS